Individualised Blood Pressure Targets Versus Standard Care Among Critically Ill Patients With Shock

Recruiting N/A Interventional Study
Critical Illness Shock
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
1,260 (estimated)
Sponsor
Rakshit Panwar · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Aim The aim of the proposed RCT is to determine effectiveness of a strategy, where MAP (mean arterial blood pressure) targets during vasopressor therapy for shock in ICU are individualized based on patients' own pre-illness MAP that would be derived as an average of up to five most recent pre-illness blood pressure readings. Hypothesis We hypothesize that targeting a patient's pre-illness MAP dur…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ICU patients aged greater than or equal to 40 years * The patient is deemed to be in shock, defined as clinician-initiated vasopressor/inotropic therapy AND supported by any of the following within the last 24 hours: * Lactate level greater than or equal to 2 mmol/l or base…
Contacts

Rakshit Panwar, PhD, MD, FCICM, MBBS

+61240420951

rakshitpanwar@hotmail.com

CONTACT

Flonda Probert

REACTSHOCKRCT@newcastle.edu.au

CONTACT